Literature DB >> 26334260

Glucose promotes secretion-dependent renal cyst growth.

Andre Kraus1, Gunnar Schley1, Karl Kunzelmann2, Rainer Schreiber2, Dorien J M Peters3, Ruth Stadler4, Kai-Uwe Eckardt1, Bjoern Buchholz5.   

Abstract

UNLABELLED: Polycystic kidney diseases are characterized by the development of numerous bilateral renal cysts that continuously enlarge resulting in a decline of kidney function due to compression of intact nephrons. Cyst growth is driven by transepithelial chloride secretion which depends on both intracellular cAMP and calcium. Mechanisms that are involved in the regulation of the underlying secretory pathways remain incompletely understood. Here we show that glucose concentration has a strong impact on cyst growth of renal tubular cells within a collagen matrix as well as in embryonic kidneys deficient or competent for Pkd1. Glucose-dependent cyst growth correlates with the transcriptional induction of the calcium-activated chloride channel anoctamin 1 (ANO1) and its increased expression in the apical membrane of cyst-forming cells. Inhibition of ANO1 with the specific inhibitor CaCCinh-AO1 significantly decreases glucose-dependent cyst growth in both models. Ussing chamber analyses revealed increased apical chloride secretion of renal tubular cells upon exposure to high glucose medium which can also be inhibited by the use of CaCCinh-AO1. These data suggest that glycemic control may help to reduce renal cyst growth in patients with polycystic kidney disease. KEY MESSAGE: Renal cyst growth depends on glucose concentration in two in vitro cyst models. High glucose leads to upregulation of the calcium-activated chloride channel ANO1. High glucose promotes calcium-activated chloride secretion via ANO1. Glucose-dependent secretion can be inhibited by a specific inhibitor of ANO1.

Entities:  

Keywords:  Anoctamin 1; Chloride secretion; Cyst growth; Diabetes mellitus type 2; Glucose; Polycystic kidney disease

Mesh:

Substances:

Year:  2015        PMID: 26334260     DOI: 10.1007/s00109-015-1337-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  38 in total

Review 1.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

2.  Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage.

Authors:  Kelli M Sas; Hong Yin; Wayne R Fitzgibbon; Catalin F Baicu; Michael R Zile; Stacy L Steele; May Amria; Takamitsu Saigusa; Jason Funk; Marlene A Bunni; Gene P Siegal; Brian J Siroky; John J Bissler; P Darwin Bell
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-22

3.  High glucose and free fatty acids induce beta cell apoptosis via autocrine effects of ADP acting on the P2Y(13) receptor.

Authors:  Chanyuan Tan; Ulrikke Voss; Siv Svensson; David Erlinge; Björn Olde
Journal:  Purinergic Signal       Date:  2012-09-01       Impact factor: 3.765

4.  Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.

Authors:  Andreas L Serra; Diane Poster; Andreas D Kistler; Fabienne Krauer; Shagun Raina; James Young; Katharina M Rentsch; Katharina S Spanaus; Oliver Senn; Paulus Kristanto; Hans Scheffel; Dominik Weishaupt; Rudolf P Wüthrich
Journal:  N Engl J Med       Date:  2010-06-26       Impact factor: 91.245

Review 5.  Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease.

Authors:  Sara Terryn; Anh Ho; Renaud Beauwens; Olivier Devuyst
Journal:  Biochim Biophys Acta       Date:  2011-01-19

6.  Adaptation to hypoxia in the diabetic rat kidney.

Authors:  C Rosenberger; M Khamaisi; Z Abassi; V Shilo; S Weksler-Zangen; M Goldfarb; A Shina; F Zibertrest; K-U Eckardt; S Rosen; S N Heyman
Journal:  Kidney Int       Date:  2007-10-03       Impact factor: 10.612

7.  Modulation of intracellular Ca2+ by glucose in MDCK cells: role of endoplasmic reticulum Ca(2+)-ATPase.

Authors:  Y H Lien; X Wang; R J Gillies; R Martinez-Zaguilan
Journal:  Am J Physiol       Date:  1995-04

8.  CFTR is activated through stimulation of purinergic P2Y2 receptors.

Authors:  Diana Faria; Rainer Schreiber; Karl Kunzelmann
Journal:  Pflugers Arch       Date:  2008-11-12       Impact factor: 3.657

9.  CFTR-adenylyl cyclase I association responsible for UTP activation of CFTR in well-differentiated primary human bronchial cell cultures.

Authors:  Wan Namkung; Walter E Finkbeiner; A S Verkman
Journal:  Mol Biol Cell       Date:  2010-06-16       Impact factor: 4.138

10.  Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.

Authors:  Isaline Rowe; Marco Chiaravalli; Valeria Mannella; Valeria Ulisse; Giacomo Quilici; Monika Pema; Xuewen W Song; Hangxue Xu; Silvia Mari; Feng Qian; York Pei; Giovanna Musco; Alessandra Boletta
Journal:  Nat Med       Date:  2013-03-24       Impact factor: 53.440

View more
  9 in total

1.  Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease.

Authors:  Jacob A Torres; Samantha L Kruger; Caroline Broderick; Tselmeg Amarlkhagva; Shagun Agrawal; John R Dodam; Michal Mrug; Leslie A Lyons; Thomas Weimbs
Journal:  Cell Metab       Date:  2019-10-17       Impact factor: 27.287

2.  Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.

Authors:  Katharina Hopp; Emily K Kleczko; Berenice Y Gitomer; Michel Chonchol; Jost Klawitter; Uwe Christians; Jelena Klawitter
Journal:  Am J Physiol Renal Physiol       Date:  2022-01-17

Review 3.  Sodium-glucose cotransporter inhibition in polycystic kidney disease: fact or fiction.

Authors:  Baris Afsar; Rengin Elsurer Afsar; Atalay Demiray; Sevval Altay; Hakan Korkmaz; Abdulmecit Yildiz; Adrian Covic; Alberto Ortiz; Mehmet Kanbay
Journal:  Clin Kidney J       Date:  2022-01-31

4.  Loss of Polycystin-1 causes cAMP-dependent switch from tubule to cyst formation.

Authors:  Julia Katharina Scholz; Andre Kraus; Dominik Lüder; Kathrin Skoczynski; Mario Schiffer; Steffen Grampp; Johannes Schödel; Bjoern Buchholz
Journal:  iScience       Date:  2022-05-05

5.  P2Y2R is a direct target of HIF-1α and mediates secretion-dependent cyst growth of renal cyst-forming epithelial cells.

Authors:  Andre Kraus; Steffen Grampp; Margarete Goppelt-Struebe; Rainer Schreiber; Karl Kunzelmann; Dorien J M Peters; Jens Leipziger; Gunnar Schley; Johannes Schödel; Kai-Uwe Eckardt; Bjoern Buchholz
Journal:  Purinergic Signal       Date:  2016-08-26       Impact factor: 3.765

6.  Apoptosis and autophagy in polycystic kidney disease (PKD).

Authors:  Kristen L Nowak; Charles L Edelstein
Journal:  Cell Signal       Date:  2019-12-24       Impact factor: 4.315

Review 7.  Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential.

Authors:  Kristen L Nowak; Katharina Hopp
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 8.237

8.  Macrophage migration inhibitory factor is regulated by HIF-1α and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.

Authors:  Wajima Safi; Andre Kraus; Steffen Grampp; Johannes Schödel; Bjoern Buchholz
Journal:  J Mol Med (Berl)       Date:  2020-09-04       Impact factor: 4.599

Review 9.  The Ca2+-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases?

Authors:  Yani Liu; Zongtao Liu; KeWei Wang
Journal:  Acta Pharm Sin B       Date:  2020-12-09       Impact factor: 11.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.